Joseph Podolski resigned as president, CEO and board member of Repros Therapeutics Inc. to pursue other interests.
Larry Dillaha, CEO of CavtheRx, has been appointed to serve as interim president and CEO, effective Feb. 2.
Repros CEO resigns; interim CEO named
Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion
Global M&A by the Numbers: Q2 2022
Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms
Infographic 2022 Top Tech Trends Shaping Corporations
Joseph Podolski resigned as president, CEO and board member of Repros Therapeutics Inc. to pursue other interests.
Larry Dillaha, CEO of CavtheRx, has been appointed to serve as interim president and CEO, effective Feb. 2.